+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bone Morphogenetic Protein Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Bone Morphogenetic Protein Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Bone Morphogenetic Protein Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011048
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior healthcare executives face mounting pressure to drive innovation, control costs, and adapt to evolving patient needs. The Bone Morphogenetic Protein (BMP) market is at the center of this shift, presenting leaders with unique opportunities and critical challenges as advanced regenerative therapies become standard in orthopedic and dental care.

Market Snapshot: Bone Morphogenetic Protein Market Growth

The Bone Morphogenetic Protein market expanded from USD 1.88 billion in 2024 to USD 2.17 billion in 2025, registering robust advancement. Projected to maintain a CAGR of 14.85%, the sector is anticipated to reach USD 4.31 billion by 2030. This trajectory illustrates accelerating adoption across medical systems worldwide, led by increasing demand for flexible, minimally invasive solutions and evolving reimbursement models. Decision-makers must understand these core growth drivers to unlock emerging potential.

Scope & Segmentation

This report offers comprehensive coverage of the Bone Morphogenetic Protein ecosystem across product portfolios, application settings, user environments, distribution strategies, and key geographic markets.

  • Product Types: BMP-2, BMP-7
  • Applications: Dental Regeneration, Orthopedic Trauma, Spinal Fusion
  • End Users: Ambulatory Surgical Centers, Clinics (Dental Clinics, Orthopedic Clinics), Hospitals
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies (Chain and Independent)
  • Geographic Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering United Kingdom, Germany, France, Russia, and others), Asia-Pacific (with China, India, Japan, Australia, South Korea, Indonesia, and additional countries covered)
  • Key Companies: Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson, Orthofix Medical Inc., Globus Medical, Inc., NuVasive, Inc., RTI Surgical Holdings, Inc., Baxter International Inc., Integra LifeSciences Holding Corporation

Key Takeaways for Senior Decision-Makers

  • Bone Morphogenetic Protein solutions are critical to modern regenerative medicine, offering established value in bone repair and dental reconstruction strategies.
  • Technological advancements such as recombinant DNA, novel delivery scaffolds, and digital surgical planning are expanding clinical applications and improving precision.
  • Stakeholder collaboration among R&D, regulatory, and clinical operations is driving more personalized and outpatient-focused BMP use, aligning with trends in minimally invasive care.
  • Market segmentation reveals strong demand for BMP-2 in spinal procedures and BMP-7 in dental and maxillofacial indications, supporting specialization among suppliers.
  • Geographic differences highlight mature markets’ focus on outcomes and evidence, while rapidly developing regions invest in capacity-building and technology transfer.
  • Competitive differentiation is attained through innovative product development and alignment with evolving supply and reimbursement models, favoring organizations that demonstrate agility and clinical relevance.

Tariff Impact: Navigating Global Market Pressures

In 2025, revised US tariffs on medical device components and reagents essential to BMP manufacturing applied upward cost pressure throughout the value chain. This shift prompted manufacturers to reevaluate sourcing, pivot to domestic and regional supply agreements, and proactively adapt pricing to maintain market access. Hospitals and surgical centers responded with heightened focus on transparent pricing and predictable reimbursement arrangements, while BMP suppliers forged value-based contracts to reinforce clinical and economic benefits for healthcare providers. These responses safeguard access and long-term adoption despite near-term disruptions.

Methodology & Data Sources

Market insights derive from a rigorous methodology combining primary interviews with orthopedic surgeons, periodontists, procurement executives, and regulatory experts alongside reviews of peer-reviewed publications, clinical trial registries, and agency releases. Data triangulation and quality control ensure balanced, validated market perspectives to support well-informed, actionable decisions.

Why This Report Matters

  • Empowers executives to make data-driven investment and sourcing decisions for competitive positioning in the high-growth Bone Morphogenetic Protein market.
  • Enables strategic assessment of product, technology, and geography-specific opportunities through clear segmentation and actionable insight into evolving healthcare dynamics.

Conclusion

Senior leaders equipped with this comprehensive analysis can confidently chart strategies to capture the full business value of advanced Bone Morphogenetic Protein solutions. The report supports balanced, forward-thinking responses to shifting clinical, regulatory, and supply trends.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bone Morphogenetic Protein Market, by Product Type
8.1. Introduction
8.2. BMP-2
8.3. BMP-7
9. Bone Morphogenetic Protein Market, by Application
9.1. Introduction
9.2. Dental Regeneration
9.3. Orthopedic Trauma
9.4. Spinal Fusion
10. Bone Morphogenetic Protein Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.3.1. Dental Clinics
10.3.2. Orthopedic Clinics
10.4. Hospitals
11. Bone Morphogenetic Protein Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
11.4.1. Chain Pharmacy
11.4.2. Independent Pharmacy
12. Americas Bone Morphogenetic Protein Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bone Morphogenetic Protein Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bone Morphogenetic Protein Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Stryker Corporation
15.3.3. Zimmer Biomet Holdings, Inc.
15.3.4. Johnson & Johnson
15.3.5. Orthofix Medical Inc.
15.3.6. Globus Medical, Inc.
15.3.7. NuVasive, Inc.
15.3.8. RTI Surgical Holdings, Inc.
15.3.9. Baxter International Inc.
15.3.10. Integra LifeSciences Holding Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BONE MORPHOGENETIC PROTEIN MARKET MULTI-CURRENCY
FIGURE 2. BONE MORPHOGENETIC PROTEIN MARKET MULTI-LANGUAGE
FIGURE 3. BONE MORPHOGENETIC PROTEIN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BONE MORPHOGENETIC PROTEIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY BMP-2, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY BMP-7, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DENTAL REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ORTHOPEDIC TRAUMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 45. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 47. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 78. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 82. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 84. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 88. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 96. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 100. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 102. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 106. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 114. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 126. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 130. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 138. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 142. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 144. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 150. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 156. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 162. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 168. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 172. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 174. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 180. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 184. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 186. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 190. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 192. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 209. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 211. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 215. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 217. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 221. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 241. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 277. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2024
TABLE 278. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bone Morphogenetic Protein market report include:
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Johnson & Johnson
  • Orthofix Medical Inc.
  • Globus Medical, Inc.
  • NuVasive, Inc.
  • RTI Surgical Holdings, Inc.
  • Baxter International Inc.
  • Integra LifeSciences Holding Corporation

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.31 Billion
Compound Annual Growth Rate14.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bone Morphogenetic Protein Market Size, Share & Trends Analysis Report by Type (rhBMP-2, rhBMP-7), Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial), Region, and Segment Forecasts, 2025-2030 - Product Image

Bone Morphogenetic Protein Market Size, Share & Trends Analysis Report by Type (rhBMP-2, rhBMP-7), Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial), Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Osteobiologics Market by Allografts, Bone Morphogenetic Protein, Synthetic Grafts, Demineralized Bone Matrix, Ceramic Grafts, Cell Based Grafts - Global Forecast to 2030 - Product Image

Osteobiologics Market by Allografts, Bone Morphogenetic Protein, Synthetic Grafts, Demineralized Bone Matrix, Ceramic Grafts, Cell Based Grafts - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Bone Morphogenetic Proteins - Global Strategic Business Report - Product Image

Bone Morphogenetic Proteins - Global Strategic Business Report

  • Report
  • 202 Pages
  • Global
From
Bone Morphogenetic Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Bone Morphogenetic Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Bone Morphogenetic Proteins Market Report and Forecast 2024-2032 - Product Image

Bone Morphogenetic Proteins Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From

About the Bone Morphogenetic Protein Market

The Bone Morphogenetic Protein (BMP) market is a subset of the biomaterials industry. BMPs are proteins that can induce bone and cartilage formation, and are used in a variety of medical applications, such as spinal fusion, fracture repair, and dental implants. BMPs are typically derived from recombinant DNA technology, and are used in combination with other biomaterials, such as ceramics, polymers, and metals. The BMP market is expected to grow in the coming years, driven by the increasing demand for bone and cartilage regeneration, as well as the development of new technologies and products. Additionally, the increasing prevalence of chronic diseases, such as osteoporosis, is expected to drive the demand for BMPs. Some of the major companies in the BMP market include Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, and Smith & Nephew. These companies are involved in the development, manufacturing, and marketing of BMPs and related products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.